Icon Advisers’s AstraZeneca AZN Stock Holding History

Icon Advisers’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15,000	Closed	-$2.34M	–	178
2024 Q3	$2.34M	Hold	15,000	–	–	0.49%	87
2024 Q2	$2.34M	Hold	15,000	–	–	0.53%	87
2024 Q1	$2.02M	Hold	15,000	–	–	0.44%	95
2023 Q4	$2.02M	Hold	15,000	–	–	0.46%	88
2023 Q3	$2.03M	Hold	15,000	–	–	0.5%	77
2023 Q2	$2.15M	Hold	15,000	–	–	0.55%	75
2023 Q1	$2.08M	Buy	+15,000	New	+$2.02M	0.53%	76
2020 Q3	–	Sell	-13,350	Closed	-$1.41M	–	184
2020 Q2	$1.41M	Buy	+13,350	New	+$1.38M	0.28%	125
2017 Q1	–	Sell	-9,500	Closed	-$519K	–	380
2016 Q4	$519K	Buy	+9,500	New	+$539K	0.04%	344

Other funds holding AZN

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sanders Capital

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return